Search research articles
Contact Us
Filters
Showing results (151-160 of 225) with videos related to
Page
of 23
Sort By:
Multiple Sclerosis and Related Disorders
|
July 18, 2018
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis
Y Naegelin, M Rasenack, M Andelova, et al.
Neurology
|
August 19, 2009
The challenge of follow-on biologics for treatment of multiple sclerosis
S C Reingold, J P Steiner, C H Polman, et al.
Neurology
|
October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M Mehling, V Brinkmann, J Antel, et al.
Immunity
|
September 12, 2000
The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides
A Shamshiev, A Donda, T I Prigozy, et al.
Neurology
|
July 13, 2005
Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study
L Kappos, M Clanet, M Sandberg-Wollheim, et al.
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)
|
January 1, 1993
Treatment of multiple sclerosis with 15 +/- deoxyspergualin. Design of a controlled study with close MRI-monitoring
L Kappos, E W Radü, L Bernasconi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 3, 2013
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis
G Izquierdo, P O'Connor, X Montalban, et al.
Annals of Neurology
|
January 1, 1988
Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study
L Kappos, U Patzold, D Dommasch, et al.
Journal of Internal Medicine
|
January 6, 2011
Anterior pituitary axis hormones and outcome in acute ischaemic stroke
S Neidert, M Katan, P Schuetz, et al.
AJNR. American Journal of Neuroradiology
|
August 24, 2019
Automatic Spinal Cord Gray Matter Quantification: A Novel Approach
C Tsagkas, A Horvath, A Altermatt, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 225) with videos related to
Sort By:
Page
of 23
Multiple Sclerosis and Related Disorders
|
July 18, 2018
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis
Y Naegelin, M Rasenack, M Andelova, et al.
Neurology
|
August 19, 2009
The challenge of follow-on biologics for treatment of multiple sclerosis
S C Reingold, J P Steiner, C H Polman, et al.
Neurology
|
October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M Mehling, V Brinkmann, J Antel, et al.
Immunity
|
September 12, 2000
The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides
A Shamshiev, A Donda, T I Prigozy, et al.
Neurology
|
July 13, 2005
Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study
L Kappos, M Clanet, M Sandberg-Wollheim, et al.
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)
|
January 1, 1993
Treatment of multiple sclerosis with 15 +/- deoxyspergualin. Design of a controlled study with close MRI-monitoring
L Kappos, E W Radü, L Bernasconi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 3, 2013
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis
G Izquierdo, P O'Connor, X Montalban, et al.
Annals of Neurology
|
January 1, 1988
Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study
L Kappos, U Patzold, D Dommasch, et al.
Journal of Internal Medicine
|
January 6, 2011
Anterior pituitary axis hormones and outcome in acute ischaemic stroke
S Neidert, M Katan, P Schuetz, et al.
AJNR. American Journal of Neuroradiology
|
August 24, 2019
Automatic Spinal Cord Gray Matter Quantification: A Novel Approach
C Tsagkas, A Horvath, A Altermatt, et al.
Page
of 23